Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development

SAN DIEGO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–AlivaMab Discovery Sevices and Ablexis, have partnered with Almirall to discover new therapeutic antibodies for severe dermatological conditions.
Click here to view original post